Business Wire

bioMérieux submits for FDA Clearance of the BIOFIRE ® FILMARRAY ® Pneumonia Panel

MARCY L’ÉTOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology ...
Nasdaq

bioMérieux: BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 Obtains FDA Emergency Use Authorization

MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
Nature

A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1

A novel coronavirus, later termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late December 2019, when reports of several cases of pneumonia of unknown origin were ...
technologynetworks

bioMérieux Makes a Significant Acquisition in Molecular Biology in the U.S.

bioMérieux has announced that it has entered into an agreement to acquire BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology. BioFire invented, manufactures ...
Business Wire

bioMérieux: BIOFIRE ® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 Obtains FDA Emergency Use Authorization

The BIOFIRE ® FILMARRAY ® range has the largest infectious disease pathogen menu commercially available, composed of: BIOFIRE ® Respiratory Panel (RP, RP2 and RP2 plus), identifying between 20 and 22 ...